Orthopedic Sciences, Inc. (OSI) is a physician-founded, physician-led medical device manufacturer with 27+ years of commercial experience designing, patenting, manufacturing, sterilizing, and commercializing FDA-regulated orthopedic devices that help patients delay or avoid artificial joint replacement.
Founded in March 1999 by orthopedic surgeon James K. Brannon, MD, Orthopedic Sciences, Inc. (OSI) designs, patents, manufactures, sterilizes, and commercializes FDA-regulated orthopedic devices supporting arthroscopic and subchondral joint preservation of the shoulder, hip, and knee — using the patient's own autologous biologic tissue without synthetic bone graft substitutes or implantable biologic replacement materials.
OSI has generated more than $30 million in cumulative commercial revenue over a 27-year period and has supported more than 3,000 shoulder, hip, and knee joint preservation procedures, with clinical success measured by preservation of the native joint and avoidance of arthroplasty (artificial joint replacement).
OSI's platform has already been deployed within a United States Department of Veterans Affairs Medical Center, and the company is actively expanding collaborations with the VA to advance joint preservation technologies within the federal healthcare system.
"We help doctors help more people preserve their joints." OSI is built around a single premise: patients should be able to keep the joint they were born with whenever clinically possible.
Unlike vendors focused solely on implants or biologics, OSI controls the complete product lifecycle — from scientific discovery and intellectual property development through design, manufacturing, sterilization, reimbursement, clinical implementation, and post-market surveillance.
OSI's core competencies span the full lifecycle of joint preservation technology — from device design through clinical implementation and post-market surveillance.
Disposable surgical devices for autologous bone grafting and arthroscopic joint preservation of the shoulder, hip, and knee.
Integrated products and workflows that may allow patients to delay or avoid arthroplasty (artificial joint replacement).
Operating room support-staff training delivered directly by orthopedic surgeons — including training on standardized four-person OR teams.
Sterilization validation, product traceability, and post-market surveillance under the FDA Quality Management System Regulation (QMSR).
Standardized, reimbursable outpatient procedural workflows for hospitals, ambulatory surgery centers, and federal medical treatment facilities.
Development and management of a patented orthopedic technology portfolio across the full product lifecycle.
OSI provides a fully integrated joint preservation platform combining patented medical devices, FDA-regulated manufacturing, regulatory compliance, reimbursement expertise, physician education, and commercialization into a single solution.
Single-source ownership of discovery, patents, design, manufacturing, sterilization, reimbursement, clinical implementation, and post-market surveillance.
OSI's joint preservation platform is already deployed within a United States Department of Veterans Affairs Medical Center.
Directed by a licensed orthopedic surgeon, with affiliated surgeons providing hands-on product training and clinical support.
Proprietary devices and workflows using the patient's own biologic tissue — without synthetic bone graft substitutes or implantable biologic replacements.
OSI manufactures a full catalog of disposable, patented orthopedic surgical instruments organized across six product categories — supporting every stage of an arthroscopic joint preservation procedure.

Minimally invasive tools for harvesting autologous cancellous bone and bone marrow for grafting.
View Products
Arthroscopic visualization, debridement, and microfracture instruments for shoulder, hip, and knee cartilage procedures.
View Products
Inflow/outflow tubing systems for clear visualization during hip, shoulder, and knee arthroscopy.
View Products
Low-pressure, syringe-free delivery of autologous bone marrow aspirate and cancellous bone graft.
View Products
Joint-access guidewires, needles, and depth probes supporting precise, minimally invasive portal placement.
View Products
Implants that stabilize bone graft within the femoral or humeral head following core decompression for AVN.
View ProductsFounder, Chairman of the Board, President & Chief Executive Officer
Dr. Brannon is the sole inventor of OSI's joint preservation technology platform. Since founding OSI in 1999, he has personally developed and patented the company's entire product line — including the Bone Tool, Hip Tool, TSY Shoulder Plate, and Q Arthroscopy System — while continuing to teach and practice orthopedic surgery.
Meet Dr. BrannonClient: Hospitals, Ambulatory Surgery Centers (ASCs), and a Veterans Affairs Medical Center
Designed, patented, manufactured, sterilized, and commercialized an FDA-regulated joint preservation platform supporting shoulder, hip, and knee procedures. Scope integrated engineering, regulatory affairs, intellectual property, manufacturing, physician education, reimbursement, and clinical adoption while maintaining FDA compliance and quality system requirements.
OSI seeks partnerships with federal hospitals, ambulatory surgery centers, and federal medical research organizations supporting orthopedic surgery, musculoskeletal research, and joint preservation.
Veterans Health Administration
Military Treatment Facilities
MEDCOM
Department of Defense
HHS
IHS
GSA Acquisition Programs
Musculoskeletal & Joint Preservation
| UEI | PVFBW56KF9T5 |
| CAGE Code | 17ME7 |
| SAM.gov Status | Active & Current |
| Primary NAICS | 339113 – Surgical Appliance and Supplies Manufacturing |
| Business Size | 3 employees (small business) |
| Service Area | Nationwide (United States) |
| Project Range | $50,000 – $5,000,000 |
| Socio-Economic Certifications | None currently held |
OSI prioritizes long-term partnerships involving orthopedic medical devices, physician education, regulatory compliance, clinical implementation, and post-market surveillance — for federal hospitals, ambulatory surgery centers, and medical research organizations supporting orthopedic surgery and musculoskeletal research.
OSI is not pursuing commodity medical supply contracts, unrelated medical specialties, third-party product distribution without physician implementation support, or projects outside orthopedic joint preservation and musculoskeletal care.
For teaming, procurement, or partnership inquiries with federal healthcare agencies.